Skip to content
TrialScanner

NCT04864561

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

Phase 3CompletedVALNLead

Registry record

Lead sponsor
Valneva Austria GmbH
Conditions
SARS-CoV-2 Virus Infection
Primary completion
Jul 19, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04864561 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04864561: COV-COMPARE Immunogenicity... | TrialScanner